LAS VEGAS—Patients treated with celecoxib oral solution (Elyxyb, Collegium) reported two-hour, post-dose relief from headache pain, phonophobia and photophobia, compared with those taking placebo, according to new research.
Data presented at the 2022 PAINWeek Conference included a pooled analysis of two multicenter, double-blind clinical trials involving 1,200 patients who experienced two to eight monthly headaches of moderate to severe pain.
“I’ve been working on this liquid